JMP Securities analyst Reni Benjamin initiates coverage on Inhibrx Biosciences (NASDAQ:INBX) with a Market Perform rating.
JMP Securities Initiates Coverage On Inhibrx Biosciences With Market Perform Rating
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.